skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Recombinant herpes simplex virus useful for treating neoplastic disease


Recombinant herpes simplex viruses comprising DNA encoding cytokines and methods for treating neoplastic diseases using the inventive recombinant viruses are disclosed.

Publication Date:
Research Org.:
Univ. of Chicago, IL (United States); UAB Research Foundation, Birmingham, AL (United States)
Sponsoring Org.:
OSTI Identifier:
Patent Number(s):
Application Number:
The University of Chicago (Chicago, IL) ; UAB Research Foundation (Birmingham, AL)
DOE Contract Number:  
Resource Type:
Resource Relation:
Patent File Date: 2006 Oct 11
Country of Publication:
United States

Citation Formats

Whitley, Richard J., and Roizman, Bernard. Recombinant herpes simplex virus useful for treating neoplastic disease. United States: N. p., 2010. Web.
Whitley, Richard J., & Roizman, Bernard. Recombinant herpes simplex virus useful for treating neoplastic disease. United States.
Whitley, Richard J., and Roizman, Bernard. 2010. "Recombinant herpes simplex virus useful for treating neoplastic disease". United States.
title = {Recombinant herpes simplex virus useful for treating neoplastic disease},
author = {Whitley, Richard J. and Roizman, Bernard},
abstractNote = {Recombinant herpes simplex viruses comprising DNA encoding cytokines and methods for treating neoplastic diseases using the inventive recombinant viruses are disclosed.},
doi = {},
url = {}, journal = {},
number = ,
volume = ,
place = {United States},
year = {2010},
month = {6}

Works referenced in this record:

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
journal, November 1991

Identification of human cancers deficient in antigen processing.
journal, February 1993

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma.
journal, October 1996

Modulation of T-cell function by gliomas
journal, October 1991

Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras.
journal, September 1984

Experimental therapy of human glioma by means of a genetically engineered virus mutant
journal, May 1991

Bovine GM-CSF: Molecular cloning and biological activity of the recombinant protein
journal, September 1988

Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
journal, May 1992

Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance
journal, May 1986

Interleukin 12 Secretion Enhances Antitumor Efficacy of Oncolytic Herpes Simplex Viral Therapy for Colorectal Cancer
journal, January 2001

Reduced tumorigenicity of fibrosarcomas which constitutively generate il-1α either spontaneously or following il-1α gene transfer
journal, July 1992

Considerations for the Use of Cytokine-Secreting Tumor Cell Preparations for Cancer Treatment
journal, January 1995

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
journal, June 1985

Use of clinically relevant human-scid-mouse models in metastasis research
journal, July 1997

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
journal, December 1997

IL-6 Undergoes Transition from in vitro Autocrine Growth Factor to in vivo Growth Inhibitor of B Lymphoma Cells
journal, January 1997

Expression of human immune interferon cDNA in E. coli and monkey cells
journal, February 1982

In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment.
journal, May 1993

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.
journal, May 1991

Interleukin 7 induces CD4+ T cell-dependent tumor rejection.
journal, December 1991

Construction and Characterization of Retroviral Vectors for Interleukin-2 Gene Therapy
journal, January 1997

Cytokine Gene Transfer Enhances Herpes Oncolytic Therapy in Murine Squamous Cell Carcinoma
journal, February 2001

Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells
journal, January 1982

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
journal, June 1990

Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells.
journal, January 1989

Genetic engineering of novel genomes of large DNA viruses
journal, September 1985

In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors: Case report
journal, March 1994

Genetically Engineered Attenuated Herpes Simplex Viruses
journal, November 1991

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.
journal, February 1995

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.
journal, October 1996

Experimental and Clinical Studies of Cytokine Gene-Modified Tumor Cells
journal, February 1994

Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model
journal, November 1992

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.
journal, February 1991

Cloning of interleukin 2 mRNAs from human tonsils
journal, September 1983

Characterization of a viable, noninverting herpes simplex virus 1 genome derived by insertion and deletion of sequences at the junction of components L and S.
journal, May 1983

Malignant glioma modulation of immune function: relative contribution of different soluble factors
journal, August 1991

The multistep nature of cancer
journal, April 1993

journal, April 1993

Structure and expression of a cloned cDNA for human interleukin-2
journal, March 1983

Enhancement of Interleukin-4-Mediated Tumor Regression in Athymic Mice by In Situ Retroviral Gene Transfer
journal, April 1995